Preclinical News and Research

RSS
Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

New frontiers in organ regeneration with 3D bioprinting

New frontiers in organ regeneration with 3D bioprinting

Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

Novel electrical impedance technique enhances drug testing for cardiac safety

Novel electrical impedance technique enhances drug testing for cardiac safety

FDA clears UAB startup's TIX100 for clinical trials

FDA clears UAB startup's TIX100 for clinical trials

Fatty acid inhibitor plus chemo could improve treatment efficacy for breast cancer patients with brain metastases

Fatty acid inhibitor plus chemo could improve treatment efficacy for breast cancer patients with brain metastases

Duke-NUS expands research capabilities with appointment of Professor Hendrik Luesch from UF

Duke-NUS expands research capabilities with appointment of Professor Hendrik Luesch from UF

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

FDA-approved iron-chelating drug could provide a novel way to attack ovarian tumors

FDA-approved iron-chelating drug could provide a novel way to attack ovarian tumors

Semaglutide may reduce smoking risks for diabetes patients

Semaglutide may reduce smoking risks for diabetes patients

New project launched to accelerate development and accessibility of H5N1 mRNA vaccine candidates

New project launched to accelerate development and accessibility of H5N1 mRNA vaccine candidates

GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

Insilico Medicine unveils Science42:DORA to streamline academic writing and research

Insilico Medicine unveils Science42:DORA to streamline academic writing and research

Researchers identify a potential therapeutic target for advanced multiple sclerosis

Researchers identify a potential therapeutic target for advanced multiple sclerosis

UQ opens new facility for personalized mRNA cancer vaccine development

UQ opens new facility for personalized mRNA cancer vaccine development

Insilico Medicine's PandaOmics Box enhances drug discovery with advanced AI capabilities

Insilico Medicine's PandaOmics Box enhances drug discovery with advanced AI capabilities

MD Anderson and Summit Therapeutics partner to accelerate ivonescimab development

MD Anderson and Summit Therapeutics partner to accelerate ivonescimab development

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.